Market Overview:
North America is the largest market for radiation oncology, followed by Europe and Asia-Pacific.
The external beam radiation therapy segment is the largest segment of the market, followed by
the internal radiation therapy segment. The breast cancer segment is the largest segment of the
market, followed by the lung cancer segment and the prostate cancer segment. Hospitals are
the largest end-users of radiation oncology services, followed by cancer treatment centers and
clinics.
Global radiation oncology market size is expected to be worth around USD 19.2 Billion by 2032
from USD 8.2 Billion in 2022, growing at a CAGR of 9.1% during the forecast period from 2022
to 2032.
The radiation oncology market is a promising market with a lot of potential for growth. The key
players in the market are investing heavily in research and development to develop new and
innovative radiation therapy techniques and technologies. The market is expected to continue to
grow in the coming years.
– Please check this report :@https://market.us/report/radiation-oncology-market/
Key Takeaway:
●
●
●
●
●
●
The global radiation oncology market is expected to grow at a CAGR of 9.1% from 2022
to 2032.
The growth of the market is being driven by the increasing prevalence of cancer,
technological advancements in radiation therapy techniques, and growing demand for
personalized medicine and targeted therapies.
North America is the largest market for radiation oncology, followed by Europe and
Asia-Pacific.
The external beam radiation therapy segment is the largest segment of the market,
followed by the internal radiation therapy segment.
The breast cancer segment is the largest segment of the market, followed by the lung
cancer segment and the prostate cancer segment.
Hospitals are the largest end-users of radiation oncology services, followed by cancer
treatment centers and clinics.
Market Key Players:
●
●
●
●
Varian Medical Systems, Inc.
Elekta AB
Isoray Inc.
Mevion Medical Systems
●
●
●
●
●
View Ray Technologies, Inc.
Novartis AG
Accuracy Incorporated
Provision Healthcare
Other Key Players
Regional Analysis:
-North America [United States, Canada, Mexico]
-South America [Brazil, Argentina, Columbia, Chile, Peru]
-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
-Middle East & Africa [GCC, North Africa, South Africa]
-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western
Asia]mailto:inquiry@market.us
Market Top Segmentations:
By Type
●
●
External Beam Radiation Therapy
Internal Beam Radiation Therapy
By Indication
●
●
●
●
●
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Other Indications
By End-User
●
●
●
Hospitals
Cancer Research Institutes
Other End-Users
Make an inquiry before picking up this report
@https://market.us/report/radiation-oncology-market/#inquiry
Market Challenges:
●
●
●
●
●
High cost of radiation therapy: Radiation therapy is a costly treatment option, and this
can be a barrier to access for patients, especially in developing countries.
Lack of skilled radiation oncologists and technicians: There is a global shortage of
skilled radiation oncologists and technicians, which can lead to delays in treatment and
sub-optimal outcomes for patients.
Complexities of radiation therapy: Radiation therapy is a complex treatment that
requires careful planning and execution. This can lead to errors and complications,
which can impact patient safety and outcomes.
Side effects of radiation therapy: Radiation therapy can have side effects, such as
fatigue, nausea, and vomiting. These side effects can be debilitating for patients and can
impact their quality of life.
Radioresistance of tumors: Some tumors are resistant to radiation therapy, which can
make treatment more difficult and less effective.
Contact:
Global Business Development Team – Market.us
Market.us (Powered by Prudour Pvt. Ltd.)
Send Email: inquiry@market.us
Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States
Tel: +1 718 618 4351
Website: https://market.us